1. Home
  2. OLN vs CPRX Comparison

OLN vs CPRX Comparison

Compare OLN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$28.66

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$28.97

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
CPRX
Founded
1892
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.4B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
OLN
CPRX
Price
$28.66
$28.97
Analyst Decision
Hold
Strong Buy
Analyst Count
13
1
Target Price
$25.23
$35.00
AVG Volume (30 Days)
2.1M
1.8M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
28.24
EPS
N/A
1.68
Revenue
$6,780,800,000.00
$119,072,803.00
Revenue This Year
$2.57
$9.20
Revenue Next Year
$3.51
$10.51
P/E Ratio
N/A
$17.12
Revenue Growth
3.68
16.39
52 Week Low
$18.08
$19.05
52 Week High
$30.46
$32.56

Technical Indicators

Market Signals
Indicator
OLN
CPRX
Relative Strength Index (RSI) 57.74 66.77
Support Level $22.82 $22.41
Resistance Level $30.46 $32.56
Average True Range (ATR) 1.14 1.19
MACD 0.05 0.19
Stochastic Oscillator 88.55 48.07

Price Performance

Historical Comparison
OLN
CPRX

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: